Edward Pershing - 26 Nov 2025 SCHEDULE 13D/A Report for PROVECTUS BIOPHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (PVCT)

Filing Manager: Edward Pershing
Reporting Manager: Pershing Edward
Security: PROVECTUS BIOPHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: PVCT
Shares outstanding: 466,438,390 shares
Disclosed Ownership: 49,255,894 shares
Ownership: 11%
Form type: SCHEDULE 13D/A
Filing time: 01 Dec 2025, 21:52:16 UTC
Date of event: 26 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Pershing Edward	11%	49,255,894	49,093,544	162,350	/s/ Edward Pershing	Edward Pershing, Chairman and CEO	0001689739